GRITSTONE ONCOLOGY INC's ticker is GRTS and the CUSIP is 39868T105. A total of 92 filers reported holding GRITSTONE ONCOLOGY INC in Q4 2022. The put-call ratio across all filers is 0.44 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $1,173,287 | +38.1% | 422,045 | +71.3% | 0.00% | 0.0% |
| Q4 2022 | $849,825 | +876.8% | 246,326 | +632.8% | 0.00% | – |
| Q3 2022 | $87,000 | -68.5% | 33,616 | -70.5% | 0.00% | -100.0% |
| Q2 2022 | $276,000 | -78.7% | 114,034 | -63.7% | 0.00% | -50.0% |
| Q1 2022 | $1,295,000 | +343.5% | 314,383 | +1061.2% | 0.00% | +100.0% |
| Q3 2021 | $292,000 | -64.2% | 27,074 | -69.7% | 0.00% | -75.0% |
| Q2 2021 | $815,000 | -10.9% | 89,284 | -8.0% | 0.00% | 0.0% |
| Q1 2021 | $915,000 | +3288.9% | 97,051 | +1969.8% | 0.00% | – |
| Q1 2020 | $27,000 | -97.9% | 4,689 | -96.9% | 0.00% | -100.0% |
| Q3 2019 | $1,292,000 | -57.5% | 149,643 | -45.2% | 0.01% | -60.0% |
| Q2 2019 | $3,040,000 | +5.8% | 272,834 | +26.3% | 0.02% | +78.6% |
| Q1 2019 | $2,872,000 | – | 216,038 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Versant Venture Management, LLC | 3,561,150 | $6,125,178 | 3.26% |
| Redmile Group, LLC | 8,509,126 | $14,635,697 | 0.70% |
| Avidity Partners Management LP | 2,733,800 | $4,702,136 | 0.19% |
| Frazier Life Sciences Management, L.P. | 1,430,878 | $2,461,110 | 0.16% |
| Artia Global Partners LP | 95,170 | $163,692 | 0.07% |
| Worth Venture Partners, LLC | 43,772 | $75,288 | 0.04% |
| SkyOak Wealth, LLC | 60,875 | $104,705 | 0.03% |
| Point72 Asset Management, L.P. | 5,924,867 | $10,190,771 | 0.03% |
| CORNERCAP INVESTMENT COUNSEL INC | 76,811 | $132,115 | 0.02% |
| Houlihan Financial Resource Group, Ltd. | 20,000 | $38 | 0.02% |